Literature DB >> 16449492

QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine.

Ingeborg Wilting, O M Smals, N J Holwerda, R H Meyboom, M L de Bruin, T C G Egberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16449492     DOI： 10.1176/appi.ajp.163.2.325

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  15 in total

Review 1.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

2.  QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa.

Authors:  Blair Ritchie; Mark L Norris
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-02

Review 3.  Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence.

Authors:  Matthew P Rochester; Allison M Kane; Sunny Anne Linnebur; Danielle R Fixen
Journal:  Ther Adv Drug Saf       Date:  2018-05-04

Review 4.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

5.  Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Authors:  Christopher Kogut; Ericka Breden Crouse; W Victor R Vieweg; Mehrul Hasnain; Adrian Baranchuk; Geneviève C Digby; Jayanthi N Koneru; Antony Fernandez; Anand Deshmukh; Jules C Hancox; Ananda K Pandurangi
Journal:  Ther Adv Drug Saf       Date:  2013-10

6.  Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Authors:  S Rajamani; L L Eckhardt; C R Valdivia; C A Klemens; B M Gillman; C L Anderson; K M Holzem; B P Delisle; B D Anson; J C Makielski; C T January
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

7.  WCD LifeVest: risk stratification in a case of Tako-Tsubo cardiomyopathy with QT interval prolongation.

Authors:  S Peters; H U Klein
Journal:  Herz       Date:  2011-03-26       Impact factor: 1.443

8.  Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.

Authors:  Mitesh J Borad; Arundhati D Soman; Martin Benjamin; Daniel Casa; Waibhav D Tembe; Barbara F Piper; Ramesh Ramanathan; Raoul Tibes; Gayle Jameson; Karen Ansaldo; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2012-12-16       Impact factor: 3.850

Review 9.  Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

Authors:  W Victor R Vieweg; Mark A Wood; Antony Fernandez; Mary Beatty-Brooks; Mehrul Hasnain; Anand K Pandurangi
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 10.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.